GLP-1 boosts insulin secretion from pancreatic beta cells in a glucose-dependent manner (meaning it only works when blood glucose is elevated, reducing hypoglycemia risk), suppresses glucagon secretion from pancreatic alpha cells (reducing glucose production by the liver), slows gastric emptying (prolonging satiety and reducing postprandial glucose spikes), and starts GLP-1 receptors in the brain (very the hypothalamus) to reduce appetite and food intake
This should be done under the guidance of a qualified healthcare professional, such as a dermatologist, who can ensure that the treatment is tailored to your specific needs
DOI: 10.3390/antiox13060624 24
Metformin ameliorates inflammatory bowel disease by suppression of the STAT3 signaling pathway and regulation of the between Th17/treg balance
Jakubczyk K, Dec K, Kaduska J, Kawczuga D, Kochman J, Janda KJPmloPTL